According to Sonoma Pharmaceuticals's latest financial reports the company's total liabilities are $7.92 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-03-31 | $8.25 M | -18.66% |
2022-03-31 | $10.14 M | 5.44% |
2021-03-31 | $9.62 M | 7.69% |
2020-03-31 | $8.93 M | 125.74% |
2019-03-31 | $3.95 M | 2.04% |
2018-03-31 | $3.88 M | -3.67% |
2017-03-31 | $4.02 M | 9.96% |
2016-03-31 | $3.66 M | 22.34% |
2015-03-31 | $2.99 M | -65.7% |
2014-03-31 | $8.72 M | 2.88% |
2013-03-31 | $8.48 M | -2.55% |
2012-03-31 | $8.7 M | 25.03% |
2011-03-31 | $6.96 M | 119.45% |
2010-03-31 | $3.17 M | -0.16% |
2009-03-31 | $3.17 M | -61.17% |
2008-03-31 | $8.18 M | -32.08% |
2007-03-31 | $12.04 M | 125.17% |
2006-03-31 | $5.35 M | 12.94% |
2005-03-31 | $4.73 M | |
2003-03-31 | $1.04 M | 39.22% |
2002-03-31 | $0.74 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.62 B | 7,753.63% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $12.01 M | 51.54% | ๐บ๐ธ USA |